Socialist Organiser

Socialist Organiser, 1987 to 1992: the second part of the Socialist Organiser archive

When evolution doesn't work

Socialist Organiser no. 415, 14 September 1989 · scan p. 10 · about 1,222 words

Read it in the scan (PDF), scan page 10 →

Read from the scan by machine and not corrected: expect misread words, and now and then a caption or a line from a neighbouring story. For anything you quote, read the scan.

Scan page 10

COLUMN Mystic fibrosis, haemophilia, sickle cell ansemia, Duchenne muscular dystrophy - these are inherited diseases which have a devastating effect on their victims.

As I argued last week, restrictions on embryo research would make it more difficult to detect these diseases at an early stage.

However, before embryo testing becomes possible for a particular genetic disease, a whole range of research has to take place. Such research has already thrown up much important information about genetic diseases. For instance, in many cases it is now known what causes such diseases, even down to pinpointing the exact DNA sub-unit which has mutated. In others, the faulty gene has been located, making it possible to devise a test for its presence in carriers (people with the gene but without the disease) and in affected embryos (usually with two copies of the faulty gene).

In some cases, the faulty protein made by the gene has been characterised and steps towards finding a treatment can be taken. Being able to identify carriers has led to some puzzling problems.

According to Darwin's theory evolution by natural selection, harmful genes should be eliminated gradually from a population because those with it should be less able to produce offspring. But some 'faulty genes are extremely common. The gene for sickle cell anaemia (SCA) occurs in up to 40% of people in some parts of Africa and 5% of people in Britain carry the cystic fibrosis gene.

The SCA gene is common in areas with a large amount of malaria for the following reason. The faulty gene produces a mutant type of haemoglobin (the red stuff that carries oxygen in the blood). Carriers of SCA have half the normal and half the mutant haemoglobin.

This functions almost normally but crucially does not provide such a welcome environment for the malarial parasite. Carriers have a survival advantage over noncarriers and hence produce more offspring on average. Thus the SCA gene (more accurately, the Malaria Resistance gene) has spread through such populations.

Unfortunately, when two carriers pass their genes to their child, that child suffers the severely debilitating and life-shortening disease, sickle cell anaemia. When they use oxygen up faster, as in exercise, their haemoglobin crystallises, distorting their red blood cells and blocking small blood vessels. This causes weakness, pain and damage, to vital organs.

In the absence of malaria, the SCA gene should gradually decline in frequency, as its possessors are at quarter of their children will be no advantage and on average a unlikely to become parents themselves.

Once again, with the more common cystic fibrosis (CF) gene, carriers suffer no ill-effects, but those with two CF genes are seriously ill. Their lungs constantly fill with mucus and they are prone to get lung infections. With physiotherapy and modern antibiotics, average life expectancy of CF sufferers has increased to 27.

Why therefore is the CF gene so common? The incidence of 1 in 20 being a carrier is far too high to be explained by random mutations. If there was no advantage to carriers, we would expect the frequency of the gene to fall gradually since one quarter of the children of two carriers would probably die before becoming a parent.

The CF gene, recently identified and isolated, seems to reduce the permeability of membranes to the chloride ion and this is thought to be an advantage during epidemics of diarrhoeal diseases such as cholera. Deaths occur because of massive losses of electrolytes such as chloride followed by loss of water. CF carriers may be less prone to such dehydration and hence survive longer and have more children on average.

It is now possible to identify the 2 million or so CF carriers in Britain. Where a couple are both carriers, their foetuses can be screened and, if found to be potential sufferers, abortion can be offered.

Another strangely common gene is that for Tay-Sachs disease (TSD). Some 1 in 30 Jewish Americans carry it and it is common in other Ashkenazi Jewish communities. Sufferers have two TSD genes and this results in a build-up of a fatty chemical in certain nerve cells. The cells, mainly in parts of the brain, become grossly swollen.

By the age of one year, the child is weak, retarded and has difficulty eating. Blindness follows with death by the age of three. It is thought by some scientists who have looked at the history of families with TSD genes that carriers have a higher resistance to tuberculosis.

Another common genetic disease, phenylketonuria (PKU) is also too common to be explained by chance mutations (about 1 in 60 are carriers). Victims are unable to break down excess quantities of an amino acid which is essential in small amounts but toxic in large amounts.

The result is severe mental retardation and death by thirty. However, it is possible to prevent this by early detection followed by a diet low in that amino acid. No advantage to carriers has yet been found.

A few genetic problems seem more common than expected for a rather peculiar reason. As much as 80% of fertilised eggs go on to be spontaneously aborted but foetuses carrying genes for juvenile onset diabetes seem less prone to this.

This formerly fatal disease can now be treated by insulin injections and so it seems that genes for JOD are likely to become more frequent as their possessors can now have children.

Other diseases, such as haemophilia, Duchenne muscular dystrophy (DMD) and Huntington's chorea (HC) are mucn rarer and may be the result of random mutation.

The first two are carried on the X chromosome. Since males have only one X chromosome, they need only one copy of the faulty gene to get the disease. Females need two faulty genes and this occurs extremely rarely. With the advent of effective treatment for haemophiliacs, the incidence of haemophilia genes is likely to increase. However, abortion of male foetuses of carriers of haemophilia and of DMD should virtually eliminate these diseases (though the genes will survive in carriers). Huntington's chorea is unusual in that just one copy of the gene will cause the disease. It is also unusual in that the symptoms, continuous involuntary movements, a progressive dementia and death after about 12 years, only appear in midlife. By then, the victim has usually had children of whom 50% will also develop the disease.

Therefore, having once arisen by a chance mutation, there is little or nothing to stop the gene from surviving. Natural selection can only operate by reducing or increasing the fitness of a living creature to reproduce but the HC gene has no effect on this.

Screening all members of an affected family will reveal those at risk of passing on the gene (though they will also know the unpalatable truth of their own fate). Foetuses can then be screened for the gene.

The information made available by modern genetics could help eliminate much suffering but it must be accurate and be used in a responsible way. In some cases, carriers of SCA genes have been discriminated against, both socially and in employment.

However, TSD is being tackled in America and Israel and in Italy the debilitating blood disease, thalassaemia, is being confronted by a mixture of screening, counselling and selective abortion. Births of victims have fallen by 60%.

• Information from Nature.

← Contents of Socialist Organiser no. 415

Something wrong on this page? Tell us →